Target Price | $180.88 |
Price | $161.13 |
Potential | 12.26% |
Number of Estimates | 25 |
25 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $180.88. This is 12.26% higher than the current stock price. The highest price target is $209.00 29.71% , the lowest is $155.00 3.80% . | |
A rating was issued by 31 analysts: 18 Analysts recommend Procter & Gamble to buy, 12 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 12.26% . Most analysts recommend the Procter & Gamble stock at Purchase. |
22 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $85.1b . This is 1.39% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $86.1b 2.66% , the lowest is $84.0b 0.11% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $85.1b | 1.23% |
2026 | $88.0b | 3.40% |
2027 | $91.2b | 3.65% |
2028 | $95.0b | 4.22% |
20 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $24.1b . This is 6.10% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $25.5b 12.15% , the lowest is $23.0b 1.40% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $24.1b | 4.32% |
2026 | $25.5b | 5.83% |
2027 | $27.1b | 6.14% |
2028 | $28.2b | 4.09% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 28.32% | 3.06% |
2026 | 28.99% | 2.37% |
2027 | 29.68% | 2.38% |
2028 | 29.65% | 0.10% |
11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $16.0b . This is 17.04% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.8b 22.93% , the lowest is $15.3b 11.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.2b | 2.03% |
---|---|---|
2025 | $16.0b | 12.76% |
2026 | $17.4b | 9.02% |
2027 | $18.7b | 7.01% |
2028 | $19.8b | 6.15% |
2024 | 16.87% | 0.43% |
---|---|---|
2025 | 18.79% | 11.38% |
2026 | 19.81% | 5.43% |
2027 | 20.46% | 3.28% |
2028 | 20.83% | 1.81% |
11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $6.79 . This is 17.07% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $7.13 22.93% , the lowest is $6.49 11.90% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.79 | 12.79% |
2026 | $7.40 | 8.98% |
2027 | $7.92 | 7.03% |
2028 | $8.41 | 6.19% |
Current | 27.79 | 13.52% |
---|---|---|
2025 | 23.74 | 14.57% |
2026 | 21.77 | 8.30% |
2027 | 20.35 | 6.52% |
2028 | 19.17 | 5.80% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.76 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.46 .
This results in the following potential growth metrics and future valuations:
Current | 4.82 | 5.01% |
---|---|---|
2025 | 4.76 | 1.34% |
2026 | 4.60 | 3.29% |
2027 | 4.44 | 3.52% |
2028 | 4.26 | 4.05% |
Current | 4.52 | 6.09% |
---|---|---|
2025 | 4.46 | 1.38% |
2026 | 4.31 | 3.29% |
2027 | 4.16 | 3.52% |
2028 | 3.99 | 4.05% |
Procter & Gamble...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.